Effects of depression on the survival of pancreatic adenocarcinoma

Pancreas

Volumn 32, Issue 1, 2006, Pages 58-61

  Sheibani Rad, Shahin ^a   Velanovich, Vic ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Chemotherapy and or radiation therapy; Depression; Pancreatic cancer; Surgical resection; Survival time

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PANCREAS SURGERY; PRIORITY JOURNAL; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SURVIVAL TIME;

EID: 29144451945     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpa.0000191643.17173.d3     Document Type: Article

References (36)

1. Yasmin J. Nervous symptoms at earliest manifestations of cancer of the pancreas. JAMA. 1931;96:1664-1668.
2. Fras IL, Parson JS. Comparison of psychiatric symptoms in carcinoma of the pancreas with those in some other intra-abdominal neoplasms. Am J Psychiatry. 1967;123:1553-1562.
3. Jacobsson L, Ottosson JO. Initial mental disorders in carcinoma of pancreas and stomach. Acta Psychitr Scand Suppl. 1971;221:120-127.
4. Pomara N, Gershon S. Treatment-resistant depression in an elderly patient with pancreatic carcinoma: case report. J Clin Psychiatry. 1984;45:439-440.
5. Hofer M, Wolff C, Friedman S. A psychoendocrine study of mourning in relation to adrenocortical function. Psychosom Med. 1972;34:492-504.
6. Mason J. Psychological stress and endocrine function, In: Sachar E, ed. Topics in Psychoendocrinology. New York: Grune & Stratton; 1975, pp. 1-18.
7. Carroll B, Curtis G, Mendels J. Cerebrospinal fluid and plasma free Cortisol concentration in depression. Psychol Med. 1976;6:235-244.
8. Carroll B, Curtis G, Davies B. Urinary free cortisol excretion in depression. Psychol Med. 1976;6:43-50.
9. Schleifer S, Keller S, Meyerson A. Lymphocyte function in major depressive disorder. Arch Gen Psychiatry. 1984;41:484-486.
10. Schleifer S, Keller S, Camerino M. Suppression of lymphocyte stimulation following bereavement. JAMA. 1983;250:374-377.
11. Kronfol Z, Silva J, Greden J. Impaired lymphocyte function in depressive illness. Life Sci. 1983;33:241-247.
12. Schleifer S, Keller S, Siris S. Depression and immunity: lymphocyte function in ambulatory depressed patients, hospitalized schizophrenic patients and patients hospitalized for herniography. Arch Gen Psychiatry. 1984;42:129-133.
13. Cameron JL, Crist DW, Sitzmann JV, et al. Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg. 1991;161:120-125.
14. Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy for cancer of the head of the pancreas: 201 patients. Ann Surg. 1995;221:721-733.
15. Lillemoe KD. Current management of pancreatic carcinoma. Ann Surg. 1995;221:133-148.
16. Yeo CJ. Pancreatic cancer: 1998 update. J Am Coll Surg. 1998;187:429-442.
17. Nitecki SS, Sarr MG, Colby TV, et al. Long-term survival after resection for ductal adenocarcinoma of the pancreas: is it really improving? Ann Surg. 1995;221:59-66.
18. Conlon KC, Klimstra DS, Brennan MF. Long-term survival after curative resection for pancreatic ductal adenocarcinoma: clinicopathologic analysis of 5-year survivors. Ann Surg. 1996;223:273-279.
19. Carr JA, Ajlouni M, Wollner I, et al. Adenocarcinoma of the head of the pancreas: Effects of surgical resection and nonsurgical therapy or survival - a ten-year experience. Am Surg. 1999;65:1143-1149.
20. Kelsen DP, Portenoy RK, Thaler HT, et al. Pain and depression in patients with newly diagnosed pancreas cancer. J Clin Oncol. 1995;12:748-755.
21. Massie MJ, Holland JC. Depression and the cancer patient. J Clin Psychiatry. 1990;51(suppl):12-17.
22. Carney CP, Jones L, Woolson RF, et al. Relationship between depression and pancreatic cancer in the general population. Psychosom Med. 2003;65:884-888.
23. Zabora J, Britzenhofeszoc K, Curbow B, et al. The prevalence of psychological distress by cancer site. Psychooncology. 2001;10:19-28.
24. Hjeri K, Andersen EW, Keiding N, et al. Depression as a prognostic factor for breast cancer mortality. Psychosomatics. 2003;44:24-30.
25. Somerset V, Stout SC, Miller AH, et al. Breast cancer and depression. Oncology. 2004;18:1021-1034.
26. Goodwin JS, Zhang DD, Ostir GV. Effect of depression on diagnosis, treatment, and survival of older women with breast cancer. J Am Geriatr Soc. 2004;52:106-111.
27. Brown KW, Levy AR, Rosberger Z, et al. Psychological distress and cancer survival: a follow-up 10 years after diagnosis. Psychosom Med. 2003;65:636-643.
28. Litofsky NS, Forale E, Anderson F Jr, et al. Depression in patients with high-grade glioma: results of the Glioma Outcomes Project. Neurosurgery. 2004;54:358-366.
29. DeBoer MF, Ryckman RM, Pruyn JF, et al. Psychosocial correlates of cancer relapse and survival: a literature review. Patient Edu Courns. 1999;37:215-230.
30. Chang G, Orav EJ, Tong MY, et al. Predictors of 1-year survival assessed at the time of bone marrow transplantation. Psychosomatics. 2004;45:378-385.
31. Chang G, Orav EJ, McNarara T, et al. Depression, cigarette smoking, and hematopoetic stem cell transplantation outcome. Cancer. 2004;101:782-789.
32. Bergenmer M, Nilssan B, Hansson J, et al. Anxiety and depressive symptoms measured by the hospital anxiety and depression scale as predictors of time to recurrence in localized cutaneous melanoma. Acta Oncol. 2004;43:161-168.
33. Fuller H, Schmidt M. Prognostic value of depressive coping and depression in survival of lung cancer patients. Psychooncology. 2004;13:359-363.
34. Stojadinovic A, Brooks A, Hoos A, et al. An evidence-based approach to the surgical management of resectable pancreatic adenocarcinoma. J Am Coll Surg. 2003;1996:9954-9964.
35. Neoptolemos JP, Stocken DD, Friess H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med. 2004;350:1200-1210.
36. El Kammar FG, Grossbard ML, Kozuch PS. Metastatic pancreatic cancer: Emerging strategies in chemotherapy and palliative care. Oncologist. 2003;8:18-24.